Citizens cuts price targets on Integra LifeSciences and Newmark Group
Citizens lowered its price target on Integra LifeSciences to $22 from $25 and on Newmark Group to $17 from $22, Dow Jones Newswires reported.
- published on Newsmetry
- original source published
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner. connect the api →
what happened
Citizens lowered its price target on Integra LifeSciences (IART) to $22 a share from $25. Dow Jones Newswires reported the change, citing ratings data from Benzinga.
In a separate update from the same brokerage, the target for Newmark Group (NMRK) was cut to $17 from $22. Both revisions were published within about half an hour of each other on the same day.
why it matters
Changes like these usually affect individual stocks rather than the market as a whole. For investors they signal that an analyst has revised the outlook for these companies, and they can add some volatility on the day of publication.
tags
instruments
sources
- Integra LifeSciences Price Target Cut to $22.00/Share From $25.00 by Citizens — Dow Jones Newswires, 22 October 2026 at 15:09 UTC
- Newmark Group Price Target Cut to $17.00/Share From $22.00 by Citizens — Dow Jones Newswires, 22 October 2026 at 15:35 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
the public page opens no earlier than 15 minutes after we detect the story. approved stories may reach the api sooner.
get stories in real time ↗